Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study on CNS Prophylaxis With Liposome-Encapsulated Cytarabine in Association With a Lineage-Targeted and MRD-Oriented Postremission Strategy in Adult ALL

NCT00795756 is registered in ClinicalTrials.gov with Northern Italy Leukemia Group as lead sponsor.

NCT NCT00795756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study on CNS Prophylaxis With Liposome-Encapsulated Cytarabine in Association With a Lineage-Targeted and MRD-Oriented Postremission Strategy in Adult ALL
Lead sponsor
Northern Italy Leukemia Group
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2013
Enrollment
145 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia